[DISCLOSURE] Celltrion (068270) announced on Dec. 17 that its Herzuma, a biosimilar of Roche’s Herceptin, has been granted final approval for sales from US Food and Drug Administrations.
Celltrion’s Herzuma obtains final approval from USFDA
PUBLISHED : Dec. 17, 2018 - 09:26:03
[DISCLOSURE] Celltrion (068270) announced on Dec. 17 that its Herzuma, a biosimilar of Roche’s Herceptin, has been granted final approval for sales from US Food and Drug Administrations.